Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.
about
Systematic review: third-line susceptibility-guided treatment for Helicobacter pylori infectionSystematic review and meta-analysis: susceptibility-guided versus empirical antibiotic treatment for Helicobacter pylori infectionA review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.Choosing a benchtop sequencing machine to characterise Helicobacter pylori genomesTrends in secondary antibiotic resistance of Helicobacter pylori from 2007 to 2014: has the tide turned?Glutathione and multidrug resistance protein transporter mediate a self-propelled disposal of bismuth in human cells.Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidenceHow antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Helicobacter pylori: evidence-based review with a focus on immigrant populations.Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.Treatment of Helicobacter pylori infection 2013.Helicobacter pylori: future perspectives in therapy reflecting three decades of experience.Attempts to enhance the eradication rate of Helicobacter pylori infectionHelicobacter pylori: management in 2013.Review: clinical management of Helicobacter pylori infection in China.A prospective evaluation of levofloxacin-based triple therapy for refractory Helicobacter pylori infection in Australia.Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro.ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.Rifabutin Containing Triple Therapy and Rifabutin with Bismuth Containing Quadruple Therapy for Third-Line Treatment of Helicobacter pylori Infection: Two Pilot Studies.Helicobacter pylori first-line and rescue treatments in the presence of penicillin allergy.Helicobacter pylori: tailored therapy with novel sequential quadruple therapies.Letter: curing Helicobacter pylori infection in a clinical setting.Point Mutations at gyrA and gyrB Genes of Levofloxacin-Resistant Helicobacter pylori Isolates in the Esophageal Mucosa from a Venezuelan Population.Dealing with uncertainty in the treatment of Helicobacter pylori.Letter: curingHelicobacter pyloriinfection in a clinical setting - authors' reply
P2860
Q26745727-9F24E849-DB0C-4C52-913F-5BAB6207E50DQ26853010-D9611F1A-CE0C-4987-803A-7217A0B7D294Q27687842-83D90886-ECD2-4EA6-9621-1C16526B7B7EQ34807657-CFC7CC0D-DC02-471B-BE83-80ED088D0B56Q34983201-13E077AD-EBAF-49DD-A811-0A6532E9F789Q35212478-565FFDC9-CF1B-4B44-BE88-2FD407F7FFE0Q37315773-C63A32AD-21B2-44DA-A81F-42CE85D408C2Q37378899-64B61FE2-ECD3-4FE1-8201-E28BF8FCE28CQ37595765-8E66F7A5-5ABD-4FCE-9AF8-EB4DC8AE66DCQ37649367-9255C0E6-E5D4-4863-97CF-1B7E665218F1Q38134877-535055AE-6E57-4597-8934-FADEAE0E033DQ38191566-455E5A27-5D55-4E3B-B64B-C94128185C0FQ38212213-2A488A26-BFFD-43BA-A550-89EFD50A8CBEQ38212214-4524F422-FFE7-41DE-8444-48C0CA6E32E3Q38266432-C75FA186-007E-4141-AB81-B0866EE6C0A5Q38874731-4375B632-EEF4-4DBE-9BC6-DBC10D123527Q40277561-160747B2-175A-4EE8-A4C4-71AB15A7AA5CQ40378087-9D75ACB0-D246-4CE5-85C4-B0CBDB5DD9D4Q40819420-F1BC258F-0C3F-4D88-9236-4DC767948E84Q41733681-55EF6D17-2262-48CA-AB29-30F5C7D57D75Q42774068-78526A7B-B906-4907-AA28-D77013222A32Q45083479-25D49994-3193-45D5-BE3B-77880285A8E9Q50192326-6C6264BC-2B61-4D39-A1C6-1EADFB24EFFDQ52330458-0AA8EABE-B4E9-4FFC-9121-D2DAAC705FEBQ56945767-C5112760-8497-4358-ADCC-7C4FC3B745C7
P2860
Helicobacter pylori eradication in Western Australia using novel quadruple therapy combinations.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Helicobacter pylori eradicatio ...... uadruple therapy combinations.
@en
type
label
Helicobacter pylori eradicatio ...... uadruple therapy combinations.
@en
prefLabel
Helicobacter pylori eradicatio ...... uadruple therapy combinations.
@en
P2093
P2860
P356
P1476
Helicobacter pylori eradicatio ...... quadruple therapy combinations
@en
P2093
P2860
P304
P356
10.1111/APT.12089
P407
P577
2012-10-16T00:00:00Z